On April 19, 2024, Octapharma Plasma USA posted a website after discovering that the company was the target of a cyberattack. In this notice, Octapharma explains that the incident resulted in a disruption to the company’s operations, prompting an investigation. The Octopharma investigation is ongoing; however, if Octapharma confirms that consumer information was subject to unauthorized access as a result of the cyberattack, the company will be required to send out data breach notification letters to all individuals whose information was affected by the recent data security incident.
If you receive a data breach notification from Octapharma Plasma USA, it is essential you understand what is at risk and what you can do about it. A data breach lawyer can help you learn more about how to protect yourself from becoming a victim of fraud or identity theft, as well as discuss your legal options following a possible Octapharma Plasma data breach. For more information, please see our recent piece on the topic here.
Was There an Octapharma Plasma Data Breach?
Octapharma only recently announced the recent cyberattack, and thus, it’s too soon to tell whether there was an Octapharma data breach. However, hackers routinely carry out these cyberattacks with the intention of obtaining confidential consumer information they can later use to commit identity theft or sell to other criminals on the dark web.
While news of the possible Octapharma data breach is still developing, the company’s website notice provides some important information on what led up to the breach. According to this source, on April 17, 2024, Octapharma detected suspicious activity within its computer network. In response, Octapharma took its systems offline in hopes of limiting the scope of the attack. As a result, Octapharma’s U.S. facilities were closed between April 17, 2024 and April 22, 2024.
Octapharma is also in the process of investigating whether the cyberattack resulted in the unauthorized disclosure of personal information in the company’s possession. While this investigation is ongoing and the company has not yet confirmed a data breach, the BlackSuit ransomware has taken credit for the attack and claims to have obtained sensitive information about those who donated plasma through Octapharma.
On April 19, 2024, Octapharma Plasma posted a website notice describing the incident and the company’s response. If Octapharma’s investigation confirms that donor information was leaked, it will be required to send out data breach letters to anyone who was affected by the recent data security incident. These letters should provide victims with a list of what information belonging to them was compromised.
More Information About Octapharma Plasma USA
Octapharma Plasma USA is a healthcare and pharmaceutical company based in Switzerland with U.S. operations in Charlotte, North Carolina. Octapharma operates 190 plasma donation centers in 35 U.S. states. Octapharma Plasma employs more than 3,307 people and generates approximately $964 million in annual revenue.
